@article{TAU9619,
author = {Kelly A. Chiles},
title = {Hypogonadism and erectile dysfunction as harbingers of systemic disease},
journal = {Translational Andrology and Urology},
volume = {5},
number = {2},
year = {2016},
keywords = {},
abstract = {Prescription sales of Testosterone and erectile aids such as phosphodiesterase-5 inhibitors are at an all-time high, underscoring the importance of hypogonadism (HG) and erectile dysfunction (ED) to men’s health. The effect of these debilitating conditions has a major impact on the quality of men’s lives. Some risk factors for HG or ED including aging, obesity, smoking, and a sedentary lifestyle. Notably, these are the same risk factors for several other medical co-morbidities that contribute to significant morbidity and mortality in men. HG and ED often co-exist with cardiovascular disease, diabetes, and osteoporosis. This review will explore these three co-morbidities that overlap with HG and ED, and will provide a review of their relationship with each other.},
issn = {2223-4691}, url = {https://tau.amegroups.org/article/view/9619}
}